The global cerebral oximetry monitoring market size reached US$ 78.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 119.78 Million by 2028, exhibiting a growth rate (CAGR) of 7.10% during 2023-2028. The rising incidence of neurological disorders, the rising expenditure capacities of consumers, and the growing awareness regarding the early detection of cerebral hypoxia represent some of the key factors driving the market.
Cerebral oximetry monitoring and non-invasive techniques are used to measure the levels of oxygen saturation in the blood. The setup consists of an oximeter probe attached to a monitor cable that is connected to a cerebral oximeter monitor. It involves placing a probe on the forehead or scalp, which uses near-infrared light to measure the amount of oxygen in the blood. Cerebral oximetry monitoring is widely used to monitor tissue oxygen saturation, which reflects hemoglobin saturation in arterial, venous, and capillary blood. It assists in reducing the risk of cerebral injury, detecting changes in cerebral oxygenation levels, improving outcomes, and early detection of cerebral hypoxia. Besides this, cerebral oximetry monitoring is a valuable tool in clinical practice that helps to identify and treat any potential problems with blood flow to the brain.
Cerebral Oximetry Monitoring Market Trends:
The rising incidence of neurological disorders such as stroke, traumatic brain injury, and dementia across the globe is one of the key factors driving the market growth. Cerebral oximetry monitoring is commonly used to monitor cerebral oxygenation levels in stroke patients and aid in diagnosing and managing the condition. In line with this, the growing awareness regarding the early detection of cerebral hypoxia that helps in timely detection, intervention, and treatment is favoring the market growth. Moreover, the increasing demand for cerebral oximetry monitoring in aortic surgery, arrhythmia surgery, and coronary artery bypass graft surgery (CABG) procedures to minimize the risk of complications and reduce anastomotic leaks is acting as another growth-inducing factor. Apart from this, the introduction of advanced cerebral oximetry monitoring devices that are more accurate, effective, and reliable and alert clinicians about the changes in the patient’s conditions are providing an impetus to the market growth. Additionally, the increasing demand for cerebral oximetry monitoring during the COVID-19 pandemic to monitor the respiratory and neurological status of patients is propelling the market growth. Furthermore, key players are focusing on the development of advanced solutions that offer clinicians reliable, timely, and actionable monitoring to help prevent adverse events and enhance patient care and outcomes, which in turn is creating a positive outlook for the market. Other factors, including the increasing number of cardiac diseases, rising expenditure capacities of consumers, significant growth in the healthcare industry, and extensive research and development (R&D) activities, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cerebral oximetry monitoring market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on age, application, and end use.
The report has provided a detailed breakup and analysis of the cerebral oximetry monitoring market based on the age. This includes adult and pediatrics.
- Cardiac Surgery
- Vascular Surgery
A detailed breakup and analysis of the cerebral oximetry monitoring market based on the application has also been provided in the report. This includes cardiac and vascular surgery.
End Use Insights:
The report has provided a detailed breakup and analysis of the cerebral oximetry monitoring market based on the end use. This includes hospitals and clinic. According to the report, hospitals represented the largest segment.
- North America
- United Kingdom
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cerebral oximetry monitoring. Some of the factors driving the North America cerebral oximetry monitoring market included the increasing number of cardiac diseases, significant technological advancements, and the rising expenditure capacities of consumers.
The report has also provided a comprehensive analysis of the competitive landscape in the global cerebral oximetry monitoring market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
|Base Year of the Analysis
||Cardiac Surgery, Vascular Surgery
|End Uses Covered
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Edwards Lifesciences, Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Nonin Medical Inc, etc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Benefits for Stakeholders:
- IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the cerebral oximetry monitoring market from 2017-2028.
- The research study provides the latest information on the market drivers, challenges, and opportunities in the global cerebral oximetry monitoring market.
- The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the cerebral oximetry monitoring industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.